Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESCENDO)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01372956

Acronym

CRESENDO

Enrollment

4950

Registered

2011-06-14

Start date

2011-08-31

Completion date

2011-10-31

Last updated

2011-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Keywords

LDL-C, cholesterol, risk factor

Brief summary

This is a multi-centre, cross-sectional, chart review study to investigate cholesterol goal attainment rates defined by modified NCEP-ATP III guidelines and define its possible determinants among Korean dyslipidemic patients

Detailed description

MC MD

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient who has a dyslipidemia with a lipid profile result within 3 months * Patient who has a dyslipidemia without change of lipid lowering drug dosage during 3 months after lipid profile test.

Exclusion criteria

* Patient who involved in this study previously. * Patient who participated in other clinical study with study drug within 90 days.

Design outcomes

Primary

Measure	Time frame
Cholesterol goal attainment rate according to NCEP-ATP III guideline	Once, at enrollment

Secondary

Measure	Time frame
Factors for cholesterol goal achievement: Age, Family history, smoking history, waist circumstance, etc.	Once, at enrollment
Cholesterol goal attainment rate related to CHD or disease history	Once, at enrollment

Countries

South Korea

Outcome results